Skip to main content Skip to section navigation Skip to footer
OPKO Health, Inc. Corporate homepage OPKO Health, Inc. Corporate homepage
  • Company
    • About Us
    • Team
    • Partner With Us
    • Careers
    • Contact
  • Pipeline
  • Science & Technology
    • ModeX Platforms
    • Long-Acting Biologics & Peptides
    • Publications
  • Global Pharmaceuticals
    • Our Medicines
    • Global Operations
  • Investors
    • Investors Overview
    • News / Events
    • Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Governance
Site Announcement

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release
Visit BioReference Health

Press Releases

Investors

  • Investors Overview
  • News / Events
    • News / Events Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Presentations
  • Company Information
    • Company Profile
    • Proxy Materials
    • Contacts
    • FAQ
  • Financial Information
    • Financial Information Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Chart
    • Historical Data
  • SEC Filings
    • SEC Filings Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Form 8937
  • Governance
    • Governance Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • News / Events Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Jul 16, 2012 8:30 am EDT
OPKO Health Announces Appointment of Juan F. Rodriguez as Chief Financial Officer
Jun 5, 2012 9:11 am EDT
OPKO Health To Acquire Stake in Israeli Hepatitis B Vaccine Manufacturer
May 31, 2012 12:24 pm EDT
OPKO Health to Present at the Jefferies 2012 Global Healthcare Conference
May 31, 2012 10:06 am EDT
OPKO Health Receives Core Technology U.S. Patent Allowance
May 14, 2012 10:27 am EDT
OPKO Health Receives Important U.S. Patent Allowance
May 4, 2012 9:14 am EDT
OPKO Health Enters into License Agreement with International Health Technology for Next Generation Prostate Cancer Biomarker Panel
Apr 25, 2012 12:08 pm EDT
OPKO Health Receives Important U.S. Patent Allowance
Apr 12, 2012 11:46 am EDT
OPKO Health Announces the Start of Phase 3 Clinical Trials of Rolapitant for the Prevention of CINV
Apr 4, 2012 3:02 pm EDT
OPKO Health Acquires Chilean Pharmaceutical Company
Apr 3, 2012 8:55 am EDT
OPKO Health Announces License Agreement for OPKO’s Alzheimer’s Diagnostic Technology
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • Page 46
  • Page 47
  • Page 48
  • Page 49
  • Page 50
  • Page 51
  • …
  • Page 55
  • Next Pagearrow_forward
rss_feed News RSS

Sign up to receive company updates straight to your inbox.

Sign Up for Email Alerts

4400 Biscayne Boulevard
Miami, FL 33137

305-575-4100 / contact@opko.com

©2026 OPKO Health, Inc. All Rights Reserved.
  • Privacy Policy
  • Terms Of Use
  • Sitemap
  • Accessibility Statement
  • Consent Preferences